Ascendis Pharma A (ASND) Other Non-Current Assets (2012 - 2021)

Ascendis Pharma A has reported Other Non-Current Assets for 10 years, with the latest figure at $2.0 million in Q3 2021.

• Quarterly Other Non-Current Assets rose 39.13% year-over-year to $2.0 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $2.0 million (up 39.13% YoY) and the FY2020 annual result came in at $1.6 million, changed 0.06% from the prior year.
• Other Non-Current Assets declined to $2.0 million in Q3 2021 per ASND's latest filing, from $2.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.0 million in Q2 2021 and troughed at $284463.6 in Q1 2017.
• A 5-year average of $1.3 million and a median of $1.4 million in 2020 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2017 and 2018: Other Non-Current Assets retreated 13.17% in 2017, then soared 380.25% in 2018.
• Over 5 years, Other Non-Current Assets stood at $344987.7 in 2017, then jumped by 283.13% to $1.3 million in 2018, then rose by 22.52% to $1.6 million in 2019, then increased by 1.24% to $1.6 million in 2020, then gained by 23.22% to $2.0 million in 2021.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.0 million, $2.0 million, and $1.6 million for Q3 2021, Q2 2021, and Q4 2020 respectively.